Go Pro
NYSE:EVH

Evolent Health (EVH) Stock Price, News & Analysis

Evolent Health logo
$3.76 -0.05 (-1.18%)
As of 09:38 AM Eastern
This is a fair market value price provided by Massive. Learn more.

About Evolent Health Stock (NYSE:EVH)

Advanced

Key Stats

Today's Range
$3.80
$3.80
50-Day Range
$3.05
$5.95
52-Week Range
$2.10
$9.63
Volume
1,029 shs
Average Volume
2.98 million shs
Market Capitalization
$424.54 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$5.96
Consensus Rating
Moderate Buy

Company Overview

Evolent Health, Inc. (NYSE: EVH) is a healthcare technology and services company focused on helping health plans and healthcare providers transition to value-based care. Its platform and services are designed to support the management of patient populations, improve clinical outcomes, and align healthcare payments with the quality and cost effectiveness of care.

The company provides solutions that may include specialty care management, population health management, administrative services, payment integrity, clinical decision support, and technology for coordinating care. Evolent works with health plans, providers, and other healthcare organizations across areas such as oncology, cardiology, musculoskeletal care, and other high-cost or complex specialties.

Founded in 2011, Evolent primarily serves the U.S. healthcare market. The company was co-founded by Frank Williams, who previously served as its chief executive, and Seth Blackley, who has served as chief executive officer. Evolent has expanded its offerings through organic development and acquisitions focused on technology-enabled specialty care and value-based healthcare services.

AI Generated. May Contain Errors.

Evolent Health Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
62nd Percentile Overall Score

EVH MarketRank™: 

Evolent Health scored higher than 62% of companies evaluated by MarketBeat, and ranked 438th out of 897 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Evolent Health has received a consensus rating of Moderate Buy. The company's average rating score is 2.63, and is based on no strong buy ratings, 11 buy ratings, 4 hold ratings, and 1 sell rating.

  • Upside Potential

    Evolent Health has a consensus price target of $5.96, representing about 57.3% upside from its current price of $3.79.

  • Amount of Analyst Coverage

    Evolent Health has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Evolent Health's stock forecast and price target.
  • Earnings Growth

    Earnings for Evolent Health are expected to grow in the coming year, from ($0.25) to ($0.04) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Evolent Health is -0.83, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Evolent Health is -0.83, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Evolent Health has a P/B Ratio of 1.07. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Evolent Health's valuation and earnings.
  • Percentage of Shares Shorted

    13.89% of the float of Evolent Health has been sold short.
  • Short Interest Ratio / Days to Cover

    Evolent Health has a short interest ratio ("days to cover") of 5.83.
  • Change versus previous month

    Short interest in Evolent Health has recently decreased by 1.92%, indicating that investor sentiment is improving.
  • Dividend Yield

    Evolent Health does not currently pay a dividend.

  • Dividend Growth

    Evolent Health does not have a long track record of dividend growth.

  • News Sentiment

    Evolent Health has a news sentiment score of 0.17. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.51 average news sentiment score of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 3 news articles for Evolent Health this week, compared to 2 articles on an average week.
  • Search Interest

    Only 4 people have searched for EVH on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • MarketBeat Follows

    1 people have added Evolent Health to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Evolent Health insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $329,460.00 in company stock.

  • Percentage Held by Insiders

    1.48% of the stock of Evolent Health is held by insiders.

  • Percentage Held by Institutions

    Evolent Health has minimal institutional ownership at this time.

  • Read more about Evolent Health's insider trading history.
Receive EVH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Evolent Health and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

EVH Stock News Headlines

ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings research points to the first half of 2026 as a particularly rough stretch for certain holdings. Some of America's most popular stocks could take serious damage as a radical market shift plays out. Analysts at Weiss Ratings have identified five names you may want to remove from your portfolio before this unfolds. If any of these are in your portfolio, now is the time to review your positions.tc pixel
Evolent Health (EVH) Q2 2026 Earnings Call Transcript
See More Headlines

EVH Stock Analysis - Frequently Asked Questions

Evolent Health's stock was trading at $4.00 at the beginning of the year. Since then, EVH stock has decreased by 5.2% and is now trading at $3.7920.

Evolent Health, Inc (NYSE:EVH) announced its quarterly earnings data on Thursday, August, 6th. The technology company reported $0.02 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.01) by $0.03. The firm's revenue was up 46.9% on a year-over-year basis.
Read the conference call transcript
.

Evolent Health (EVH) raised $172 million in an initial public offering on Friday, June 5th 2015. The company issued 11,500,000 shares at a price of $14.00-$16.00 per share. J.P. Morgan and Goldman Sachs acted as the underwriters for the IPO and Wells Fargo Securities, William Blair, SunTrust Robinson Humphrey and Leerink Partners were co-managers.

Top institutional shareholders of Evolent Health include Squarepoint Ops LLC (0.22%), Engineers Gate Manager LP (0.17%), Public Employees Retirement System of Ohio (0.12%) and Corient Private Wealth LP (0.07%). Insiders that own company stock include Seth Blackley, Daniel Joseph Mccarthy, John Paul Johnson, Jonathan Weinberg, Diane Holder, Emily Ann Rafferty and Brendan B Springstubb.
View institutional ownership trends
.

Shares of EVH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Evolent Health investors own include Humana (HUM), American Water Works (AWK), Voyager Therapeutics (VYGR), Waste Connections (WCN), The RMR Group (RMR), DiamondRock Hospitality (DRH) and Southern First Bancshares (SFST).

Company Calendar

Last Earnings
8/06/2026
Today
9/23/2026
Next Earnings (Estimated)
11/05/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NYSE
Industry
Healthcare Technology
Sub-Industry
Healthcare Technology
Current Symbol
NYSE:EVH
CIK
1628908
Employees
4,200
Year Founded
2011

Price Target and Rating

High Price Target
$10.00
Low Price Target
$3.00
Potential Upside/Downside
+57.3%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.63
Research Coverage
16 Analysts

Profitability

EPS (Trailing Twelve Months)
($4.57)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$534.51 million
Net Margins
-24.08%
Pretax Margin
-23.94%
Return on Equity
-4.27%
Return on Assets
-1.06%

Debt

Debt-to-Equity Ratio
2.52
Current Ratio
1.24
Quick Ratio
1.24

Sales & Book Value

Annual Sales
$1.88 billion
Price / Sales
0.23
Cash Flow
$4.80 per share
Price / Cash Flow
0.79
Book Value
$3.53 per share
Price / Book
1.07

Miscellaneous

Outstanding Shares
113,060,000
Free Float
111,386,000
Market Cap
$428.72 million
Optionable
Optionable
Beta
0.84

Social Links

10 Best Stocks to Own - Fall 2026 Cover

Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Fall 2026, despite the economic uncertainty rattling markets right now. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (NYSE:EVH) was last updated on 9/23/2026 by MarketBeat.com Staff.
From Our Partners